{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:55:08Z","timestamp":1762869308778,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.htct.2022.11.010","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T22:58:33Z","timestamp":1675119513000},"page":"S131-S139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S2","title":["Economic burden of acute myeloid leukemia on patients in a resource-limited tertiary hospital in the Philippines"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9414-3218","authenticated-orcid":false,"given":"Jean Rachel M.","family":"Catapia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3856-543X","authenticated-orcid":false,"given":"Preeti Prerna M.","family":"Vaswani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corilyn Joy V.","family":"Pajares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1980-6592","authenticated-orcid":false,"given":"Erika Belinda T.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1870-5434","authenticated-orcid":false,"given":"Lynn B.","family":"Bonifacio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2022.11.010_bib0012","unstructured":"Appelbaum F., Kebriaei P., Larson, R., American Cancer Society. Typical treatment of Acute Myeloid Leukemia (Except APL) United States of America [updated May 3, 2019] In American Cancer Society [Internet] [Cited 2022 February 10] Available from:https:\/\/www.cancer.org\/cancer\/acute-myeloid-leukemia\/treating\/typical-treatment-of-aml.html"},{"issue":"Suppl 1","key":"10.1016\/j.htct.2022.11.010_bib0004","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1038\/bmt.2008.138","article-title":"The status of blood and marrow transplantation in Philippines","volume":"42","author":"Baylon","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.htct.2022.11.010_bib0005","unstructured":"Capuno J., Kraft A., Poco L.C., Quimbo S.A., Tan C.A.R. Factors associated with the delay in seeking inpatient and outpatient care services in the Philippines, UPSE Discussion Paper, No. 2017-03, University of the Philippines, School of Economics (UPSE), Quezon City [Cited 2022 February 10]. Available from: http:\/\/hdl.handle.net\/10419\/202524"},{"key":"10.1016\/j.htct.2022.11.010_bib0006","unstructured":"Philhealth Circular No. 2015-035 the guiding principle of the Z benefits. [Cited 2022 February 10] Available from: https:\/\/www.philhealth.gov.ph\/circulars\/2015\/circ035-2015.pdf"},{"key":"10.1016\/j.htct.2022.11.010_bib0022","unstructured":"Mapa C.D., PNHA press release Philippine statistics authority [Internet]; Manila, Philippines 2018; Available from: https:\/\/psa.gov.ph\/pnha-press-release\/node\/144466"},{"issue":"3","key":"10.1016\/j.htct.2022.11.010_bib0026","first-page":"659","article-title":"Concepts and definitions for \u201csupportive care,\u201d \u201cbest supportive care,\u201d \u201cpalliative care,\u201d and \u201chospice care\u201d in the published literature, dictionaries, and textbooks","volume":"21","author":"Hui","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.htct.2022.11.010_bib0025","unstructured":"Segel J. Cost-of-illness studies\u2014a primer. RTI international. [Internet] Available from: https:\/\/pdfs.semanticscholar.org\/3bbf\/0a03079715556ad816a25ae9bf232b45f2e6.pdf"},{"key":"10.1016\/j.htct.2022.11.010_bib0023","unstructured":"Census data from the Division of Hematology, Department of internal medicine 2016-2019; [Unpublished database] Philippine General Hospital Manila, Philippines"},{"issue":"1","key":"10.1016\/j.htct.2022.11.010_bib0002","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/152581601750098499","article-title":"Costs of diagnosis, treatment, and follow up of patients with acute myeloid leukemia in the Netherlands","volume":"10","author":"Uyl-de Groot","year":"2001","journal-title":"J Hematother Stem Cell Res"},{"year":"2016","series-title":"Clinical Profile and Five-Year Survival of Adult AML Patients in a Tertiary Hospital: a Retrospective Study","author":"Burog","key":"10.1016\/j.htct.2022.11.010_bib0014"},{"key":"10.1016\/j.htct.2022.11.010_bib0007","unstructured":"Philhealth Circular No. 0035s, 2013\u2014ACR policy No. 2 \u2013implementing guidelines on medical and procedure case rates taken [Cited 2022 February 10] Available from https:\/\/www.philhealth.gov.ph\/circulars\/2015\/circ035-2015.pdf"},{"key":"10.1016\/j.htct.2022.11.010_bib0008","unstructured":"Philhealth Circular No 0014-, s. 2013 updated list of cases as of 2017. [Cited 2022 February 10] Available fromhttps:\/\/www.philhealth.gov.ph\/circulars\/2017\/annexes\/0019\/AnnexA-MedicalCaseRates.pdf"},{"issue":"8","key":"10.1016\/j.htct.2022.11.010_bib0017","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/17474086.2019.1627869","article-title":"Healthcare expenses for treatment of acute myeloid leukemia","volume":"12","author":"Bewersdorf","year":"2019","journal-title":"Expert Rev Hematol"},{"issue":"3","key":"10.1016\/j.htct.2022.11.010_bib0018","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ctrv.2003.11.002","article-title":"Economic burden of acute myeloid leukemia: a literature review","volume":"30","author":"Redaelli","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.htct.2022.11.010_bib0019","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7123\/01.EJH.0000415251.75716.cb","article-title":"Cost-effectiveness of postremission intensive chemotherapy in comparison with allogeneic stem-cell transplantation in adult Egyptian patients with acute myeloid leukemia","volume":"37","author":"Hassan","year":"2012","journal-title":"Egypt J Haematol"},{"key":"10.1016\/j.htct.2022.11.010_bib0013","unstructured":"Tallman M., Altman J., Appelbaum F., Bhatt V., Bixby D., de Lima M., et al. National comprehensive cancer network guidelines version 3.2021 Acute Myeloid Leukemia (Age 18) Index AML-1 page 27 of 158. [Cited 2022 February 10]. Available from: http:\/\/nccndd.qitian-med.tech\/nccn-his\/\u6025\u6027\u9ad3\u6027\u767d\u8840\u75c5\/\u6025\u6027\u9ad3\u6027\u767d\u8840\u75c52021.3\u7248.pdf"},{"issue":"3","key":"10.1016\/j.htct.2022.11.010_bib0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.leukres.2012.09.018","article-title":"The costs of initial treatment for patients with acute myeloid leukemia in the Netherlands","volume":"37","author":"Leunis","year":"2013","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.htct.2022.11.010_bib0016","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1586\/17474086.2016.1112735","article-title":"Economic burden associated with acute myeloid leukemia treatment","volume":"9","author":"Zeidan","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.htct.2022.11.010_bib0027","unstructured":"Philippine information on USD and Philippine Peso exchange rate. Available from: https:\/\/www.in-philippines.com\/fx-rates-historic-from-1965-usd-php\/"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137922014717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137922014717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:35:44Z","timestamp":1762868144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137922014717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":19,"alternative-id":["S2531137922014717"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2022.11.010","relation":{},"ISSN":["2531-1379"],"issn-type":[{"type":"print","value":"2531-1379"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic burden of acute myeloid leukemia on patients in a resource-limited tertiary hospital in the Philippines","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2022.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular.","name":"copyright","label":"Copyright"}]}}